≡ Risteys
R9

Documentation Changelog GitHub Contact & Feedback

Vitiligo

DOID EFO MESH PheWeb

L12_VITILIGO

Vitiligo: Generalized well circumscribed patches of leukoderma that are generally distributed over symmetric body locations and is due to autoimmune destruction of melanocytes.

Endpoint definition

↥
FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 L80
Hospital discharge: ICD-9 7090F
Hospital discharge: ICD-8 70905
Cause of death: ICD-10 L80
Cause of death: ICD-9 7090F
Cause of death: ICD-8 70905

2 out of 7 registries used, show all original rules.

277

diagram downward connector

Check minimum number of events None

277

diagram downward connector

Include endpoints None

277

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

260

diagram downward connector
L12_VITILIGO

Control definitions

Control exclude L12_OTHERSKINSUBCUTIS

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 L80-L99
Name in latin Vitiligo

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 260 156 104
Unadjusted prevalence (%) 0.07 0.07 0.06
Mean age at first event (years) 45.37 44.59 46.55

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: L12_VITILIGO – Vitiligo
GWS hits:

Survival analyses between endpoints

↥

Plot

before Vitiligo
after Vitiligo

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Vitiligo

↥

Endpoint not on priority list, no data to show.